Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry

Asta Theodorsdottir, Birgit Debrabant, Melinda Magyari, Matthias Kant, Peter V. Rasmussen, Carl Fredrik Malmberg, Iver A. Norberg, Victoria Hansen, Danny Bech, Mathias F. Schmidt, Karen Schreiber, Jette L. Frederiksen, Finn Sellebjerg, Zsolt Illes^*

^*Corresponding author for this work

KI, OUH, Research unit of Neurology (Odense)
IRS - Sygehus Lillebælt, Forskningsenhed for Neurologi (Kolding)
KI, OUH, Research Unit OPEN (Odense)
Epidemiology, Biostatistics and Biodemography
IRS - Hospital Sønderjylland, Research Unit of Neurology (Sønderborg)

Rigshospitalet
Aarhus University Hospital
Odense University Hospital
Aalborg University Hospital
Regionshospitalet Viborg

Research output: Contribution to journal › Journal article › Research › peer-review

1 Ph.D. thesis

1 results

2022
Clinical outcomes and measures of progression in secondary progressive multiple sclerosis
Theódorsdóttir, Á., 21. Apr 2022, Syddansk Universitet. Det Sundhedsvidenskabelige Fakultet. 142 p.
Research output: Thesis › Ph.D. thesis

Open Access
File
27 Downloads (Pure)

Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry

Related research output

Search results

Clinical outcomes and measures of progression in secondary progressive multiple sclerosis